Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Yamamoto-Sugitani
RSK2Ser227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
TRAF6 Activation in Multiple Myeloma: A Potential Therapeutic Target
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
CD26 Is a Potential Therapeutic Target by Humanized Monoclonal Antibody for the Treatment of Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology
FOXM1 Is a Therapeutic Target in High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Therapeutic Targeting of N-Cadherin Is an Effective Treatment for Multiple Myeloma
British Journal of Haematology
Hematology
EZH2 as a Therapeutic Target for Multiple Myeloma and Other Haematological Malignancies
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
Is Mossy Fiber Sprouting a Potential Therapeutic Target for Epilepsy?
Frontiers in Neurology
Neurology
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma
International Journal of Oncology
Cancer Research
Oncology
TAK1 Is a Pivotal Therapeutic Target for Tumor Progression and Bone Destruction in Myeloma
Haematologica
Hematology